PGY-2 Thrombosis & Hemostasis Residency


PGY2 pharmacy residency programs build on Doctor of Pharmacy (Pharm.D.) education and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists in specialized areas of practice. PGY2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care or other advanced practice settings. Residents who successfully complete an accredited PGY2 pharmacy residency are prepared for advanced patient care, academic, or other specialized positions, along with board certification, if available.

Additional Program Description

The PGY2 Thrombosis and Hemostasis Pharmacy residency program at MUSC is a one-year post-graduate training program designed to prepare clinical pharmacy specialists in advanced training in thrombosis and hemostasis. Residents who complete the program are qualified to accept a position and practice in a variety of thrombosis specialty environments. As part of the extensive training residents will receive, they will be able to identify, prevent, and resolve medication-related problems, participate as active members of a multidisciplinary healthcare team, provide education to various healthcare providers and patients, conduct effective research and medication-use-evaluations, and demonstrate leadership skills.

Graduating PGY-2 Thrombosis and Hemostasis residents who successfully complete the one year program will:

  • Effectively coordinate and manage the pharmaceutical care needs of complex medical patients requiring anticoagulation inpatient or outpatient.
  • Garner skills required to precept PharmD candidates and PGY-1 pharmacy residents, to develop and modify protocols/guidelines, to present educational series to healthcare staff, to participate as part of a multidisciplinary team, and to conduct effective research

Program Design

The PGY2 Thrombosis and Hemostasis Pharmacy residency program is designed to provide the flexibility to adapt to the resident’s specific learning needs and career goals. The training is provided through concentrated clinical rotations and longitudinal experiences.

There are 7 required clinical learning experiences plus a mandatory research month in December and orientation month in July. The resident can choose to repeat a required learning experience (set up as a separate learning experience) and/or select from the elective opportunities afforded to them based on their career interests.

Required Learning Experience and Rotation Length (all 1 month in duration)

  • Orientation (July) | 1 month
  • Research (December) | 1 month
  • Medical Intensive Care Unit (MICU) | 1-2 months
  • Ambulatory Care | 1-2 months
  • Cardiology/Cardiothoracic Intensive Care Unit (CTICU) | 1 month
  • Benign hematology | 1 month
  • Emergency Medicine (EM) | 1 month
  • Neurology/Neurocritical Care | 1 month

Required Longitudinal Learning Experiences

  • Anticoagulation/LVAD Outpatient clinic (2-three month rotations)
  • On-Call | All year
  • Staffing Experience | All year
  • Research Project | All year
  • MUE | All year
  • Thrombosis and Hemostasis Management [includes Journal Club, TRAIN grant Lecture Series, Anticoagulation Committee, Seminar, Hospital or Committee Work] | All year

Elective Learning Experiences

  • Cardiac Intensive Care Unit (CICU) | 1 month
  • Anticoagulation stewardship | 1 month
  • LVAD/Ambulatory Care | 1 month
  • Medication Safety | 1 month
  • Other elective learning experiences may be considered based on resident interest and preceptor availability | 1 month